Menard Francois A

SVP,Global Generics R&D at WATSON PHARMACEUTICALS INC

Sold, on record
$503k
Dollars the filings state
Form 4 sales
2
Latest May 29, 2012
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale WATSON PHARMACEUTICALS INCPlan not stated
    Aug 5 2011

    Sold 3,953 shares at $62.51 ($247k)

    Menard Francois A, SVP,Generics R&D

    Sold 9.9% of holdings ($2.5M position)35,907 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale WATSON PHARMACEUTICALS INCPlan not stated
    May 29 +298 days

    Sold 3,467 shares at $73.89 ($256k)

    Menard Francois A, SVP,Global Generics R&D

    Sold 8.6% of holdings ($3M position)37,016 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Menard Francois A
Source
May 29, 2012WATSON PHARMACEUTICALS INCSVP,Global Generics R&DForm 4 sale3,467$256k8.6%Plan not statedSEC
Aug 5, 2011WATSON PHARMACEUTICALS INCSVP,Generics R&DForm 4 sale3,953$247k9.9%Plan not statedSEC